OLFM4 and Familial prostate cancer: Taken together, our findings suggest that OLFM4 plays a critical role in regulating progression of prostate cancer and might be useful as a novel candidate biomarker for improving diagnostic/prognostic accuracy and as a likely target for therapeutic approaches to prostate cancer.